This two day conference will provide insight and discussion on PD-1, IDO blockade, inflammatory leverage, and leveraging standards of care.
Topics
Speakers and discussions will cover a range of topics including:
PD-1 and checkpoint response profiling
IDO blockade
Myeloid leverage
Immunometabolic blockade
Inflammatory leverage
Leveraging standards of care including immunoradiotherapy and immunochemotherapy
Abcam organises its event entitled Immunometabolic adjuvants for cancer immunotherapy to be held from 26 March 2018 to 27 March 2018 in Charles Commons Building- Johns Hopkins, United States. It covers various areas of Biology and life sciences including Immunotherapy. For more information, visit the website of the conference or contact the organizer.
Add to calendar2018-03-262018-03-27Europe/LondonImmunometabolic adjuvants for cancer immunotherapyhttps://www.sciencedz.net/en/conference/34895-immunometabolic-adjuvants-for-cancer-immunotherapyCharles Commons Building- Johns Hopkins - United StatesAbcam
Disclaimer :
We aim to provide correct and reliable information about
upcoming events, but cannot accept responsibility for the text
of announcements or for the bona fides of event organizers.
Please feel free to contact us if you notice incorrect or
misleading information and we will attempt to correct it.We are not involved in the organization of any of the events listed and we do not handle registration payments on behalf of the organizers.
Subscribe Now
Subscribe to receive conference alerts and news.
Share this event
Embed this event in your webpage
Copy the text below and past it in your html code: